Kosterink JG - Search Results

1

Immunoscintigraphy as potential tool in the clinical evaluation of HER2/neu targeted therapy.

Dijkers EC, de Vries EG, Kosterink JG, Brouwers AH, Lub-de Hooge MN. Dijkers EC, et al. Among authors: kosterink jg. Curr Pharm Des. 2008;14(31):3348-62. doi: 10.2174/138161208786549425. Curr Pharm Des. 2008. PMID: 19075712 Review.

2

Preclinical characterisation of 111In-DTPA-trastuzumab.

Lub-de Hooge MN, Kosterink JG, Perik PJ, Nijnuis H, Tran L, Bart J, Suurmeijer AJ, de Jong S, Jager PL, de Vries EG. Lub-de Hooge MN, et al. Among authors: kosterink jg. Br J Pharmacol. 2004 Sep;143(1):99-106. doi: 10.1038/sj.bjp.0705915. Epub 2004 Aug 2. Br J Pharmacol. 2004. PMID: 15289297 Free PMC article.

3

Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.

Perik PJ, Lub-De Hooge MN, Gietema JA, van der Graaf WT, de Korte MA, Jonkman S, Kosterink JG, van Veldhuisen DJ, Sleijfer DT, Jager PL, de Vries EG. Perik PJ, et al. Among authors: kosterink jg. J Clin Oncol. 2006 May 20;24(15):2276-82. doi: 10.1200/JCO.2005.03.8448. J Clin Oncol. 2006. PMID: 16710024

4

Biodistribution studies of epithelial cell adhesion molecule (EpCAM)-directed monoclonal antibodies in the EpCAM-transgenic mouse tumor model.

Kosterink JG, McLaughlin PM, Lub-de Hooge MN, Hendrikse HH, van Zanten J, van Garderen E, Harmsen MC, de Leij LF. Kosterink JG, et al. J Immunol. 2007 Jul 15;179(2):1362-8. doi: 10.4049/jimmunol.179.2.1362. J Immunol. 2007. PMID: 17617629

5

Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.

Dijkers EC, Kosterink JG, Rademaker AP, Perk LR, van Dongen GA, Bart J, de Jong JR, de Vries EG, Lub-de Hooge MN. Dijkers EC, et al. Among authors: kosterink jg. J Nucl Med. 2009 Jun;50(6):974-81. doi: 10.2967/jnumed.108.060392. Epub 2009 May 14. J Nucl Med. 2009. PMID: 19443585 Free article.

6

Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer.

Dijkers EC, Oude Munnink TH, Kosterink JG, Brouwers AH, Jager PL, de Jong JR, van Dongen GA, Schröder CP, Lub-de Hooge MN, de Vries EG. Dijkers EC, et al. Among authors: kosterink jg. Clin Pharmacol Ther. 2010 May;87(5):586-92. doi: 10.1038/clpt.2010.12. Epub 2010 Mar 31. Clin Pharmacol Ther. 2010. PMID: 20357763

7

Positron emission tomography in the diagnosis and treatment management of tuberculosis.

Kosterink JG. Kosterink JG. Curr Pharm Des. 2011;17(27):2875-80. doi: 10.2174/138161211797470183. Curr Pharm Des. 2011. PMID: 21834765 Review.

8

Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.

Terwisscha van Scheltinga AG, van Dam GM, Nagengast WB, Ntziachristos V, Hollema H, Herek JL, Schröder CP, Kosterink JG, Lub-de Hoog MN, de Vries EG. Terwisscha van Scheltinga AG, et al. Among authors: kosterink jg. J Nucl Med. 2011 Nov;52(11):1778-85. doi: 10.2967/jnumed.111.092833. Epub 2011 Oct 11. J Nucl Med. 2011. PMID: 21990576 Free article.

9

Development of a radioiodinated apoptosis-inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies.

Duiker EW, Dijkers EC, Lambers Heerspink H, de Jong S, van der Zee AG, Jager PL, Kosterink JG, de Vries EG, Lub-de Hooge MN. Duiker EW, et al. Among authors: kosterink jg. Br J Pharmacol. 2012 Apr;165(7):2203-12. doi: 10.1111/j.1476-5381.2011.01718.x. Br J Pharmacol. 2012. PMID: 22014269 Free PMC article.

10

Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model.

van der Bilt AR, Terwisscha van Scheltinga AG, Timmer-Bosscha H, Schröder CP, Pot L, Kosterink JG, van der Zee AG, Lub-de Hooge MN, de Jong S, de Vries EG, Reyners AK. van der Bilt AR, et al. Among authors: kosterink jg. Clin Cancer Res. 2012 Nov 15;18(22):6306-14. doi: 10.1158/1078-0432.CCR-12-0406. Epub 2012 Sep 26. Clin Cancer Res. 2012. PMID: 23014526

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

154 results

Search Page